←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy and ctDNA, Colorectal
Van Karlyle Morris
MD
🏢MD Anderson Cancer Center🌐USA
Associate Professor of GI Medical Oncology
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Van Karlyle Morris leads CRC clinical research at MD Anderson in BRAF mutant colorectal cancer and MSI-H neoadjuvant immunotherapy. He contributed to studies of BRAF-targeted combinations and pembrolizumab in rectal MSI-H disease. His work informs biomarker-driven neoadjuvant therapy.
Share:
🧪Research Fields 研究领域
BRAF mutant CRC
MSI-H CRC neoadjuvant
anal cancer
targeted therapy CRC
NICHE cohorts
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Van Karlyle Morris 的研究动态
Follow Van Karlyle Morris's research updates
留下邮箱，当我们发布与 Van Karlyle Morris（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment